| Date | Title | Description |
| 21.03.2026 | Biotech Powerhouse Mestag Therapeutics Secures $40M for Advanced Therapies | Mestag Therapeutics has secured $40 million in new financing. This pushes its total funding past $95 million. The Cambridge-based biotech fuels its Phase 1 STARLYS clinical trial for cancer drug MST-0312. This pivotal trial begins in mid-20... |
| 17.03.2026 | Mestag Therapeutics Raises $40M in Financing | Mestag Therapeutics, a Cambridge, UK-based biotech company harnessing fibroblast immunology to develop treatments for cancer and inflammatory diseases, closed a $40m financing.
Backers includwed SV Health Investors, Johnson & Johnson, t... |
| 17.03.2026 | Mestag Therapeutics: $40 Million Raised To Advance Fibroblast Immunology Cancer Therapies Into Clinic | Mestag Therapeutics, a biotech company focused on fibroblast immunology, has announced the closing of a $40 million financing round, bringing its total funding to more than $95 million. The round was backed by SV Health Investors, Johnson &... |
| 31.01.2026 | TRexBio Secures $50M to Accelerate Treg-Targeted Immunotherapy Pipeline | TRexBio secured $50 million. This clinical-stage biotech develops precision immunoregulatory medicines. Its focus: tissue regulatory T cell (Treg) biology. Funding fuels clinical and preclinical pipeline advancement. Lead program TRB 061, a... |
| 28.01.2026 | TRexBio: $50 Million Raised To Advance Tissue-Targeted Treg Immunology Pipeline | TRex Bio, a clinical-stage biotechnology company focused on precision immunoregulatory medicines derived from tissue regulatory T cell biology, announced it closed an oversubscribed $50 million financing to support clinical and preclinical ... |
| 27.01.2026 | TRexBio Raises $50M in Funding | TRexBio, a San Francisco, CA-based clinical-stage biotechnology company, raised $50M in funding.
Backers included new investors Janus Henderson Investors, Balyasny Asset Management L.P. and Affinity Asset Advisors, as well as existing inves... |
| 13.01.2026 | Johnson & Johnson invests in DistalMotion |
Ambulatory Surgery Centers (ASCs) have emerged as the fastest growing US site of care segment in surgery. Preference for ASC convenience and quality, paired with payor policies that incentivize more cost-effective ASC-based care is driving... |
| 13.01.2026 | DistalMotion secures Johnson & Johnson investment | Ambulatory Surgery Centers (ASCs) are seeing sustained growth as patients and surgeons increasingly favor their convenience and quality of care, while payor policies continue to encourage cost-efficient outpatient procedures. In response, m... |
| 11.01.2026 | EpiBiologics Secures $107M Series B, Propelling Precision Protein Degradation for Cancer and Immunity | EpiBiologics closed a $107 million Series B. This investment accelerates its EpiTAC platform. The platform develops tissue-selective extracellular protein degraders. These target disease-driving membrane and soluble proteins. Lead candidate... |
| 10.01.2026 | EpiBiologics: $107 Million Series B Raised To Advance Tissue-Selective EGFR Degrader And Bispecific Antibody Pipeline | EpiBiologics announced it has closed a $107 million Series B financing to advance a pipeline of bispecific antibodies designed to selectively degrade extracellular protein targets in oncology and immunology. The round was co-led by GV and J... |
| 08.01.2026 | EpiBiologics Closes $107M Series B Funding | EpiBiologics, a San Mateo, CA-based company which specializes in tissue-selective extracellular protein degradation, raised $107M in Series B funding.
The round was co-led by GV (Google Ventures) and Johnson & Johnson, through its corpo... |
| 16.12.2025 | Cellular Origins Raises USD 40M in Series A Funding | Cellular Origins, a Cambridge, UK-based company that enables the manufacturing of cell therapies at scale, raised USD 40M in Series A funding.
The round was led by Johnson & Johnson, through its corporate venture capital organisation, J... |
| 15.12.2025 | Link Cell Therapies Raises $60M in Series A Financing | Link Cell Therapies, a San Francisco, CA-based oncology cell therapy company, raised $60M in Series A funding.
The round was led by Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation ... |
| 09.10.2025 | AviadoBio and UgeneX Therapeutics Announce Exclusive Option-License Agreement to Develop Next Generation Optogenetics Gene Therapy to Restore Vision in Patients with Retinal Disease | LONDON, and SHANGHAI – October 9, 2025 – AviadoBio Ltd. (“AviadoBio”), and UgeneX Therapeutics, today announced an exclusive option and license agreement for the development and commercialization of UGX-202, an investigational, AAV-based ge... |
| 18.09.2025 | Capital meets care: 10 venture capital firms transforming healthcare across Europe | Venture capital remains one of the cornerstones of Europe’s innovation landscape, fuelling the growth of startups across every sector. In our last list, we spotlighted 15 VC firms focused on sustainability, underlining how investors are sha... |
| 14.05.2025 | BioCentury to Host Grand Rounds in Chicago: Where Translational Science Meets Investors and Dealmakers | Join VCs, academic innovators and biopharma executives to connect, collaborate and accelerate innovation at the forefront of drug R&D
CHICAGO–(BUSINESS WIRE)–May 14, 2025–
Top decision-makers from across the biopharma ecosystem will con... |
| 09.12.2024 | Cala Health: Bioelectronic Medicine Leader Raises $50 Million (Growth Round) | Cala Health – a non-invasive bioelectronic medicine leader – announced it has raised the initial closing of an oversubscribed $50 million growth round, co-led by Vertex Growth Fund and Nexus NeuroTech Ventures. And all existing Cala investo... |
| 23.11.2024 | TRexBio: $84 Million (Series B) Closed To Decode Human Tissue Immune Biology | TRex Bio – a biotechnology company decoding human tissue immune biology to create revolutionary therapeutics – announced the closing of an oversubscribed $84 million Series B funding round. This funding was led by Delos Capital, with additi... |
| 16.09.2024 | ONL Therapeutics Closes $65M Series D Financing | ONL Therapeutics, an Ann Arbor, MI-based clinical-stage biopharmaceutical company focused on advancing treatments of geographic atrophy (GA) associated with dry age-related macular degeneration (AMD), raised $65M in Series D funding.
The ro... |
| 21.08.2024 | HistoSonics: A New Dawn in Non-Invasive Cancer Treatment | In the world of medical technology, innovation is the lifeblood that fuels progress. HistoSonics, a pioneer in non-invasive cancer treatment, has recently secured $102 million in Series D funding. This investment is not just a financial boo... |
| 20.08.2024 | HistoSonics: $102 Million (Series D) Raised To Scale Non-Invasive Histotripsy Platform | HistoSonics, a manufacturer of the Edison Histotripsy System and novel histotripsy therapy platforms, announced the completion of an oversubscribed $102 million Series D financing. This funding round was led by Alpha Wave Ventures, a world ... |
| 15.08.2024 | HistoSonics Secures $102M to Advance Non-Invasive Liver Tumor Treatment | What You Should Know:
– HistoSonics, a medical technology company specializing in histotripsy, a non-invasive treatment for liver tumors raises $102M in Series D financing round.
– Led by Alpha Wave Ventures, with participation from new inv... |
| 16.07.2024 | EQT Life Sciences invests in Asceneuron, a neurodegeneration therapeutics company, as part of USD 100 million Series C financing round | EQT Life Sciences invests in Asceneuron, a neurodegeneration therapeutics company, as part of USD 100 million Series C financing round
Tue, Jul 16, 2024 09:15 CET Report this content
EQT Life Sciences has invested in Asceneuron’s oversubscr... |
| 17.06.2024 | Bright Peak Therapeutics raises USD90 million to advance lead program into clinical trials |
Bright Peak Therapeutics is a biotechnology company advancing a portfolio of multifunctional immunotherapies to treat cancer and other diseases. “We are now well positioned to bring much needed innovation to the field of anti-PD-1 immune-c... |
| 29.04.2024 | Johnson & Johnson moves closer to Swiss start-ups |
Johnson & Johnson’s global innovation partnering teams provide early-stage startups and life science innovators with a single point of entry to the life sciences group. They connect potential collaborators to world-leading resources an... |
| 25.04.2024 | Dutch-based Flindr Therapeutics secures €20M to discover and develop precision oncology therapeutics | Read this article in:
Netherlands-based Flindr Therapeutics, a company focused on precision cancer treatments, announced that it has secured €20M in a Series A round of funding.
This funding will help advance the Dutch company’s cancer trea... |
| 29.11.2023 | Cradle raises $24m for GenAI biotech platform | |
| 19.10.2023 | Global accelerators propel Swiss life sciences | |
| 25.09.2023 | Biotech startup VerImmune just raised $3.1M for its cancer therapy tech | In a follow-on round, a local biotech company raised millions to help with the development of its cancer prevention tech.
VerImmune, a startup based out of Johnson & Johnson’s JLabs space in northwest DC, raised $3.1 million in a round ... |
| 27.06.2023 | Houston immunotherapy company to use $13.5M grant to further develop cancer treatments | Between Bangalore and Chennai in the Indian state of Andhra Pradesh, you’ll find the town of Tirupati. It’s home to seven peaks that host a Hindu temple complex devoted to a form of Vishnu, Venkateshvara. It is also the region from which Up... |
| 21.06.2023 | The Public Health Company Selected as a BLUE KNIGHT™ Company | PHC worries about biorisk so you don't have to
PHC Pharos Platform
The Public Health Company, a leader in the development of an early warning system for global biorisks, announces it has been selected as a BLUE KNIGHT company.
Our selection... |
| 08.06.2023 | Catalent and JLABS Symposium to Discuss Accelerated Development and Manufacturing of Biologics | SOMERSET, N.J. (PRWEB) June 08, 2023
The Catalent Applied Drug Delivery Institute, which was established as a cross-industry consortium to accelerate the adoption of advanced drug delivery technologies, today announced that it will hold a s... |
| 17.04.2023 | mHealth Startup NeurCare Named as an Awardee in the Improving Detection of Neurotoxicity in Immunotherapies QuickFire Challenge | "NeurCare aims to revolutionize early detection of neurotoxicity in immunotherapies to help patients achieve safe and effective outcomes"
LOS ANGELES (PRWEB) April 17, 2023
NeurCare, an mHealth startup incubated by Dogtown Media, ... |
| 10.04.2023 | DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES RESIDENCY AT JLABS @ SHANGHAI | SINGAPORE, April 10, 2023 /PRNewswire/ -- Respiree announced today that it has become a resident of Johnson & Johnson Innovation – JLABS @ Shanghai ('JLABS')[1] from February 21, 2023 , in order to expand its footprint with the goal of ... |
| 30.03.2023 | Accelerated Development and Manufacturing of Oral Small Molecules to be Discussed by Catalent Applied Drug Delivery Institute and JLABS | SOMERSET, N.J. (PRWEB) March 30, 2023
The Catalent Applied Drug Delivery Institute, which was established as a cross-industry consortium to accelerate the adoption of advanced drug delivery technologies, today announced that it will hold a ... |
| 24.01.2023 | Dexcom Ventures Invests in MedCrypt’s Medical Device Cybersecurity Platform | What You Should Know:
The global wearable medical device market size is currently valued at $21.3 billion and is expected to grow 28% by 2030. Cybersecurity remains one of the biggest hurdles for connected devices across all areas of health... |
| 20.12.2022 | Immunophotonics named as an awardee in QuickFire Challenge: Lung Cancer & Physical Trauma | SAINT LOUIS, MISSOURI, USA, December 20, 2022 /EINPresswire.com/ -- Immunophotonics, Inc., a clinical-stage biotech company focused on immuno-oncology, was recently named one of six awardees by Johnson & Johnson Innovation in its Innova... |
| 08.11.2022 | BIORCHESTRA announces that BMD-001 reduces Amyloid-β and Tau in non-human primate animal model of Alzheimer's Disease at the RNA Leaders USA Conference in Boston | BOSTON, Nov. 8, 2022 /PRNewswire/ -- Dr. Branden Ryu, CEO and Founder of BIORCHESTRA Ltd. (S. Korea), was a featured speaker at a plenary session of the RNA Leaders Congress USA in Boston, MA, on October 18th, 2022. Dr Ryu focused on the ne... |
| 06.10.2022 | flowbone raises CHF 2.1 million to bring nanomedicine-based bone repair to the market | Founded by Dr. Ulrike Kettenberger, Prof Dominique Pioletti, and Dr. Régis Gauderon and incorporated in July 2020, flowbone leverages regenerative nanomedicine to transform the care of millions of patients with bone diseases and disorders, ... |
| 06.10.2022 | CHF 2.1 million to bring nanomedicine-based bone repair to the market | |
| 06.10.2022 | flowbone raises CHF 2.1 million to bring nanomedicine-based bone repair to the market | flowbone raises CHF 2.1 million to bring nanomedicine-based bone repair to the market 06.10.2022 16:00, Tracy Woodley linkedIn facebook twitter instagram youtube -->
flowbone, an EPFL spin-off active in the field of bone regeneration, ha... |
| 23.08.2022 | BIORCHESTRA appointed Dr. Gabriel Helmlinger (Ph.D., DABT) as Head of Translational and Clinical Pharmacology, Toxicology | BOSTON, Mass., Aug. 23, 2022 /PRNewswire/ -- BIORCHESTRA, headquartered in Daejeon, South Korea, appointed Dr. Gabriel Helmlinger (Ph.D., D.A.B.T.) as Vice-President, Head of Translational & Clinical Pharmacology, Toxicology.
Dr. Helmli... |
| 18.05.2022 | J&J-backed Locus closes $35M financing to push CRISPR-based antibacterial drug into phase 2/3 | Locus Biosciences—a clinical-stage biotech developing a new class of CRISPR-based antibacterial drugs—just closed a $35 million financing round with backing from Johnson & Johnson.
The $35 million included a series B equity financing an... |
| 14.01.2022 | Verana Health Raises $150M to Expand Real-World Data Network | What You Should Know:
Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights from an exclusive real-world data network, today announced a $150 million Series E funding round led by Johnson... |
| 11.01.2022 | MedCrypt Raises $25M for Medical Device Cybersecurity Platform | What You Should Know:
This round stems from the growing need for improved medical device cybersecurity as the deployment of use medical devices increases. Typically, hospitals average 10 to 15 medical devices per patient bed. There are appr... |
| 04.11.2021 | Trendlines Announces Acquisition of Portfolio Company OrthoSpin Ltd. | MISGAV, Israel, Nov. 4, 2021 /PRNewswire/ -- The Trendlines Group Ltd. ("Trendlines") is pleased to announce the 100% acquisition ("Acquisition") of its 26.9%-owned (fully diluted) portfolio company, OrthoSpin Ltd. (&quo... |
| 20.10.2021 | Global pharma companies grow interest in Swiss Lifesciences | |
| 05.10.2021 | Акселераторы, о которых должны знать MedTech-стартапы | Акселераторы, о которых должны знать MedTech-стартапы |
| 05.10.2021 | Акселераторы, о которых должны знать MedTech-стартапы | Акселераторы, о которых должны знать MedTech-стартапы |
| 05.10.2021 | Must-know accelerators for MedTech-startups | Must-know accelerators for MedTech-startups |
| 20.09.2021 | Clinical progression and €8M funding for Calypso Biotech | Calypso Biotech’s lead program, CALY-002, is a best-in-class therapeutic antibody that binds to and neutralizes interleukin-15 (IL-15). IL-15 controls immune pathways critically involved in disease onset and maintenance, as well as tissue d... |
| 26.08.2021 | Going with Our Gut: Backing Two Trailblazing Healthcare Startups | When it comes to healthcare investments, the Micron Ventures team is just getting started. Our team is always on the hunt to find startups who are truly innovative in their application of AI and Machine Learning (ML) across various problem ... |
| 14.07.2021 | Johnson & Johnson Innovation announces extension of innovation partnering office at Monash University in collaboration with Victorian State Government to accelerate the life-sciences hub | |
| 26.04.2021 | The winners of INVEST Pitch Perfect are….. | The INVEST Pitch Perfect contest at the INVEST conference April 19-23 cast a spotlight on healthcare startups across biopharma, diagnostics, health IT, health services and medical devices.
Judges scored the finalists from each track based o... |
| 06.11.2020 | Johnson & Johnson Innovation Launches 3 Collaborations to Advance Healthcare in China | Front row (left to right): Jian Chen, Vice President, Xian Janssen Pharmaceuticals; Dan Wang, Head, Johnson & Johnson Innovation, Asia Pacific; Sharona Tao, Leader, Communications & Public Affairs, Johnson & Johnson China; Jenni... |
| 13.01.2020 | Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference | The J.P. Morgan Healthcare Conference has positioned itself as not only the first, but perhaps the most important event of the global health care conference calendar year. Motionette
On Monday, January 13, like a swarm of honey bees, thousa... |
| 23.12.2019 | African tech startups netted over $6m in collective prize money in 2019 [List] | African tech startups this year tapped millions of dollars by taking part in and winning startup competitions — at least over $6-million collectively, by Ventureburn’s calculations.
The biggest cash prize went to South African insurtech st... |
| 23.12.2019 | African tech startups netted over $6m in collective prize money in 2019 [List] | African tech startups this year tapped millions of dollars by taking part in and winning startup competitions — at least over $6-million collectively, by Ventureburn’s calculations.
The biggest cash prize went to South African insurtech sta... |
| 16.12.2019 | New drug development: ‘It’s the ecosystem, stupid’ | A trio of biopharma observers recently published in STAT an analysis relevant to the ongoing drug pricing debate in Washington. The response has not been pretty. In short, the authors suggest that since two reviewed pharmaceutical companies... |
| 14.10.2019 | Top 10 VCs investing in medical device companies | They include NEA, Versant Ventures, SOSV and Innova Memphis
Healthtech is a big and broad space, so much so that there are whole subsectors that see more investments than entire industries.
Medical device companies, for example, raised $2.9... |
| 05.09.2019 | Here are the six winners of Johnson & Johnson’s innovation challenge | Healthcare giant Johnson & Johnson today announced the six winners of the Champions of Science Africa Innovation Challenge 2.0 at the 28th World Economic Forum on Africa in Cape Town.
The winning teams will get share of $300 000 prize p... |
| 05.09.2019 | Here are the six winners of Johnson & Johnson’s innovation challenge | Healthcare giant Johnson & Johnson today announced the six winners of the Champions of Science Africa Innovation Challenge 2.0 at the 28th World Economic Forum on Africa in Cape Town.
The winning teams will get share of $300 000 prize ... |
| 18.06.2019 | Cara Care Nabs $7M to Expand Digital Therapuetic App for Digestive Diseases | Berlin, Germany-based digital health company Cara Care, announced today that it has secured $7 million in Series A funding led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Barcelona-based VC firm Asabys Partners with particip... |
| 26.02.2019 | String of successes for Merck Serono spin-offs | |
| 18.01.2019 | Startup competitions from top healthcare companies | They include competitions from Humana, UnitedHealth Group, Aetna, Pfizer and UCSF
If you're a startup seeking opportunities to get funded, educated or connected, startup competitions are a great resource.
Vator has been holding its own comp... |
| 15.11.2018 | SunRegen wins international biotech startup competition | |
| 14.11.2018 | Here’s all you need to know about the Africa Innovation Challenge 2.0 | US-based pharmaceutical company Johnson & Johnson has launched the second edition of its Africa Innovation Challenge and is calling on innovators from across Africa to submit their entries before 16 January.
This year’s edition — which... |
| 14.11.2018 | Here’s all you need to know about the Africa Innovation Challenge 2.0 | US-based pharmaceutical company Johnson & Johnson has launched the second edition of its Africa Innovation Challenge and is calling on innovators from across Africa to submit their entries before 16 January.
This year’s edition — which ... |
| 13.06.2018 | Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo | DAVIS, Calif., June 13, 2018 /PRNewswire/ -- Evolve BioSystems, Inc., the leading infant gut microbiome company, today announced that it has completed a $40 million Series C round of funding co-led by the Bill & Melinda Gates Foundation... |
| 22.12.2017 | Toronto’s thriving AI ecosystem serves as a model for the world | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
While you were looking the other way, Toronto hum... |
| 29.05.2017 | 5 medtech companies to watch at JLABS @ Toronto | Like a blood test looking for biological markers, WinterLight’s technology seeks to isolate cadence, word choice and other voice markers that might indicate a neurological issue.
“Different disorders have different clusters of variables ass... |
| 23.03.2017 | Johnson & Johnson Innovation Launches Singapore QuickFire Challenge Competition in Collaboration with ETPL and SMART to Accelerate Solutions for Diabetes and Other Metabolic Diseases | SINGAPORE, March 23, 2017 /PRNewswire/ -- Johnson & Johnson Innovation, Division of Johnson & Johnson (China) Investment Ltd., announced today a collaboration with A*STAR's ETPL, through its Diagnostics Development Hub, and Singapor... |
| 08.12.2016 | Johnson & Johnson and HAX team to foster health device hardware development | Johnson & Johnson, of BAND-AID and Tylenol (and about half the inventory at your local drugstore) fame, is teaming up with Shenzhen-based accelerator and hardware investor HAX to put some weight behind health startups.
Johnson & Joh... |
| 04.11.2016 | Innovation challenge: Johnson & Johnson opens entries | Healthcare brand, Johnson & Johnson has recently opened up entries to their new Africa Innovation Challenge.
The challenge will aim to support and develop the continent’s entrepreneurs as well as continue to develop consumer health solu... |
| 04.11.2016 | Johnson & Johnson launches $100,000 Innovation Challenge to support consumer health solutions | Share this article:
Johnson and Johnson’s Africa Innovation Challenge (AIC), an initiative to support Africa’s vibrant and growing innovation ecosystem is now accepting submissions to the AIC 2017 challenge. Individuals and companies that h... |
| 04.11.2016 | Innovation challenge: Johnson & Johnson opens entries | Healthcare brand, Johnson & Johnson has recently opened up entries to their new Africa Innovation Challenge.
The challenge will aim to support and develop the continent’s entrepreneurs as well as continue to develop consumer health sol... |
| 03.11.2016 | $100k Africa Innovation Challenge goes live | Africa Innovation Challenge participants with the best solutions will receive up to $100 000 in funding and mentorship.
US pharmaceutical company Johnson & Johnson has launched the Africa Innovation Challenge, an initiative to support A... |
| 02.03.2016 | Daily funding roundup - March 2, 2016 | Blippar raised $54M; Rocksbox bagged $8.7M Series A; Influitive secured $8.2M funding
goTenna, a device that enables smartphone users to communicate without cell towers, wifi routers or even satellites. The company announced a $7.5 million ... |
| 11.01.2016 | Daily funding roundup - January 11, 2016 | Cardiorentis secured $60M; BioAlta raised $45M; V-Wave completed $28M funding
Wamda Capital, A Dubai based venture capital firm with Fadi Ghandour as its Chairman & CEO, has invested $1 million in The Luxury Closet, an online marketplac... |
| 11.01.2016 | Aelix Therapeutics completes Series A funding of €11.5M ($12.7M) for therapeutic HIV vaccine | Aelix Therapeutics, a drug development company specialized in the discovery and development of immunotherapies against HIV infection, today announces that it has completed a Series A funding round of €11.5 M ($12.7 M). Ysios Capital, a Span... |
| 18.12.2015 | Daily funding roundup - December 18, 2015 | Pave secured $300M; Navitor Pharmaceuticals, Inc received $33M; Checkpoint Surgical raised $7.5M
Jolla Ltd., a Finnish mobile company and developer of open mobile operating system Sailfish OS, today announced that it has closed its C invest... |
| 06.10.2015 | J&J’s medtech arm partnering out, pushing innovation agenda | “I think the funding and the budgets are there, and we have the ability to fund and develop R&D internally at scale,” Fitchet said. “But we are very selective about the highest potential technologies.”
The company’s looking at outcomes-... |
| 29.09.2015 | Asceneuron raises CHF 30 million | |
| 28.08.2015 | Morning Read: Novo Nordisk acquires 2 U.S. biotechs targeting diabetes, insurers get greenlight on double digit rate hikes | — PharmaTimes
Some insurers have received the double digit rate increases they were seeking after state commissioners agreed that the increases were needed to cover higher-than-expected claims from sick people who signed up for individual p... |
| 27.08.2015 | Roundup: Uber Clears $1 Billion for Expansion Efforts in China | We've got funding for a few smaller stage startup companies today, which is always good to see. However, the news taking the cake this morning is Uber's $1 billion in funding to expand efforts into China – it's absolutely massive and pushes... |
| 03.03.2015 | Johnson & Johnson opening another JLABS accelerator in South San Francisco | “That allows them to be free and really build value,” she said. The initial San Francisco spot, a 24-000 square-foot facility in the Dogpatch neighborhood, is at capacity and Johnson & Johnson needed a larger presence in the Bay Area in... |
| 17.09.2014 | J&J launches Neuroscience Catalyst to seed academic spinouts | Janssen is helping operationalize the academic spinouts, as well as raise downstream venture financing, and design a clear exit strategy. Much like many of these pharma-academia partnerships, J&J will also provide in-kind support, allow... |
| 21.08.2014 | Tissue Regeneration Systems to Collaborate with J&J, DePuy Synthes | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Earlier this summer, Johnson & Johnson Innovation and DePuy Synthes Products announced a new collaboration with Plymouth, MI-based Tissue Regeneration Systems (TRS) to hel... |
| 31.07.2014 | CircleUp Partners with Johnson & Johnson | Equity crowdfunding platform CircleUp, a site that focuses on consumer and retail private company investments, has announced a collaboration with Johnson & Johnson Innovation and the Johnson & Johnson Consumer Companies, to identify... |
| - | Morning Read: Novo Nordisk acquires 2 U.S. biotechs targeting diabetes, insurers get greenlight on double digit rate hikes | TOP STORIES
Novo Nordisk is acquiring Indiana-based Calibrium LLC and MB2 LLC, both of which are relatively fresh on the scene and working on drug targets for diabetes and metabolic diseases. The financial details are still being kept under... |
| - | Fusion Pharmaceuticals Raises $105 Million In Oversubscribed Series B Financing |
Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced the completion of a $105 million Series B financing led by Varian and new investo... |
| - | Fusion Pharmaceuticals Completes Oversubscribed Series A Financing Totaling $46 Million USD to Develop Targeted Alpha Therapeutics | HAMILTON, ONTARIO, September 25, 2017 – Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced it has completed a second closing of its Se... |
| - | 5 medtech companies to watch at JLABS @ Toronto | With more than 40 companies on its roster, Johnson & Johnson Innovation’s life sciences incubator JLABS @ Toronto is celebrating a successful first year. One of eight such facilities around North America, JLABS provides early stage star... |
| - | Johnson & Johnson opening another JLABS accelerator in South San Francisco | Life sciences giant Johnson & Johnson Innovation announced the opening of a fourth JLABS accelerator in South San Francisco that will accommodate up to 50 startups that span the healthcare landscape.
It’s the fourth JLABS to open, follo... |
| - | J&J launches Neuroscience Catalyst to seed academic spinouts | There’s a serious dearth of psychiatric drugs under development, but Janssen is taking a gander at speeding up innovation on that front.
The project’s called Neuroscience Catalyst. Over the course of three years, Janssen and Johnson & J... |
| - | With a renewed global focus on mental health, a solution is in sight | In recent months, solving the global mental health crisis has taken center stage as organizations re-focus with the urgency, call to action, and dedication that’s necessary to drive innovation.
Experts agree, partnerships between government... |
| - | The winners of INVEST Pitch Perfect are….. | The INVEST Pitch Perfect contest at the INVEST conference April 19-23 cast a spotlight on healthcare startups across biopharma, diagnostics, health IT, health services and medical devices.
Judges scored the finalists from each track based o... |
| - | Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treatments | HAMILTON ONTARIO, February 23, 2017 – Fusion Pharmaceuticals, a newly formed biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced the closing of a $25 million Series A financing... |
| - | J&J’s medtech arm partnering out, pushing innovation agenda | Following the trend of the broader pharmaceutical world, Johnson & Johnson’s medtech division is interested and ready for partnering out – pushing a decentralized business model that focuses heavily on external collaboration.
“We have t... |
| - | Minnesota company raises $29.6 million for implantable hypertension technology | CVRx, a Minneapolis-based firm that has developed proprietary implantable technology for the treatment of high blood pressure and heart failure, has raised $29.6 million for advancing clinical trials of its Barostim Neo, as well as expandin... |
